B-cell-activating factor affects the occurrence of thyroid autoimmunity in chronic hepatitis C patients treated with interferon alpha

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Kajiyama, Yusuke ^a   Kikuchi, Kentaro ^a   Takai, Atsuko ^a   Hosoya, Naomi ^a   Hoshino, Hiromi ^b   Hino, Kunihiko ^b   Miyakawa, Hiroshi ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b Delta Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; PEGINTERFERON ALPHA; RIBAVIRIN; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; ALPHA INTERFERON; ANTIVIRUS AGENT; AUTOANTIBODY; BIOLOGICAL MARKER; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; PEROXIDASE; RECOMBINANT PROTEIN;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; THYROXINE BLOOD LEVEL; AGE; AUTOIMMUNITY; BIOSYNTHESIS; BLOOD; DRUG COMBINATION; DRUG EFFECT; HEPATITIS C VIRUS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SEX DIFFERENCE; THYROID GLAND; VIROLOGY;

AGE FACTORS; ANTIVIRAL AGENTS; AUTOANTIBODIES; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PEROXIDASE; POLYETHYLENE GLYCOLS; PROGNOSIS; RECOMBINANT PROTEINS; RIBAVIRIN; SEX FACTORS; THYROID GLAND;

EID: 84858223170     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/247973     Document Type: Article

References (23)

1. Pfeffer L. M., Dinarello C. A., Herberman R. B., Williams B. R. G., Borden E. C., Bordens R., Walter M. R., Nagabhushan T. L., Trotta P. P., Pestka S., Biological properties of recombinant -interferons: 40th anniversary of the discovery of interferons Cancer Research 1998 58 12 2489 2499 (Pubitemid 28275413)
2. Russo M. W., Fried M. W., Side effects of therapy for chronic hepatitis C Gastroenterology 2003 124 6 1711 1719 (Pubitemid 36617688)
3. Prummel M. F., Laurberg P., Interferon- and autoimmune thyroid disease Thyroid 2003 13 6 547 551
4. Koh L. K., Greenspan F. S., Yeo P. P., Interferon- induced thyroid dysfunction: three clinical presentations and a review of the literature Thyroid 1997 7 6 891 896 (Pubitemid 28041664)
5. Mandac J. C., Chaudhry S., Sherman K. E., Tomer Y., The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification Hepatology 2006 43 4 661 672
6. Moore P. A., Belvedere O., Orr A., Pieri K., LaFleur D. W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D., Li Y., Galperina O., Giri J., Roschke V., Nardelli B., Carrell J., Sosnovtseva S., Greenfield W., Ruben S. M., Olsen H. S., Fikes J., Hilbert D. M., BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator Science 1999 285 5425 260 263 (Pubitemid 29330000)
7. Shu H. B., Hu W. H., Johnson H., TALL-1 is a novel member of the TNF family that is down-regulated by mitogens Journal of Leukocyte Biology 1999 65 5 680 683 (Pubitemid 29227061)
8. Schneider P., Mackay F., Steiner V., Hofmann K., Bodmer J. L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R. H., Browning J. L., Tschopp J., BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth Journal of Experimental Medicine 1999 189 11 1747 1756 (Pubitemid 29272691)
9. Mukhopadhyay A., Ni J., Zhai Y., Yu G. L., Aggarwal B. B., Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor- B, and c-jun NH Journal of Biological Chemistry 1999 274 23 15978 15981
10. Gross J. A., Johnston J., Mudri S., Enselman R., Dillon S. R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C., Moore M., Littau A., Grossman A., Haugen H., Foley K., Blumberg H., Harrison K., Kindsvogel W., Clegg C. H., TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease Nature 2000 404 6781 995 999 (Pubitemid 30243593)
11. Cheema G. S., Roschke V., Hilbert D. M., Stohl W., Elevated serum B lymphcyte stimulator levels in patients with systemic immune-based rheumatic diseases Arthritis Rheumatism 2001 44 6 1313 1319 (Pubitemid 32537529)
12. Stohl W., Metyas S., Tan S. M., Cheema G. S., Oamar B., Xu D., Roschke V., Wu Y., Baker K. P., Hilbert D. M., B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations Arthritis and Rheumatism 2003 48 12 3475 3486 (Pubitemid 37531913)
13. Groom J., Kalled S. L., Cutler A. H., Olson C., Woodcock S. A., Schneider P., Tschopp J., Cachero T. G., Batten M., Wheway J., Mauri D., Cavill D., Gordon T. P., Mackay C. R., Mackay F., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjgren's syndrome Journal of Clinical Investigation 2002 109 1 59 68 (Pubitemid 34052542)
14. Zhang J., Roschke V., Baker K. P., Wang Z., Alarcn G. S., Fessler B. J., Bastian H., Kimberly R. P., Zhou T., Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus Journal of Immunology 2001 166 1 6 10 (Pubitemid 32038409)
15. Mariette X., Roux S., Zhang J., Bengoufa D., Lavie F., Zhou T., Kimberly R., The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjgren's syndrome Annals of the Rheumatic Diseases 2003 62 2 168 171 (Pubitemid 36135394)
16. Pers J. O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., Youinou P., BAFF overexpression is associated with autoantibody production in autoimmune diseases Annals of the New York Academy of Sciences 2005 1050 34 39 (Pubitemid 41129420)
17. Tomer Y., Villanueva R., Hepatitis C and thyroid autoimmunity: is there a link? American Journal of Medicine 2004 117 1 60 61 (Pubitemid 38798023)
18. Antonelli A., Ferri C., Pampana A., Fallahi P., Nesti C., Pasquini M., Marchi S., Ferrannini E., Thyroid disorders in chronic hepatitis C American Journal of Medicine 2004 117 1 10 13 (Pubitemid 38798015)
19. Tomer Y., Menconi F., Interferon induced thyroiditis Best Practice and Research 2009 23 6 703 712
20. Tomer Y., Blackard J. T., Akeno N., Interferon alpha treatment and thyroid dysfunction Endocrinology and Metabolism Clinics of North America 2007 36 4 1051 1066 (Pubitemid 350026253)
21. Izumi Y., Komori A., Yasunaga Y., Hashimoto S., Miyashita T., Abiru S., Yatsuhashi H., Ishibashi H., Migita K., Rheumatoid arthritis following a treatment with IFN-alpha/ribavirin against HCV infection Internal Medicine 2011 50 9 1065 1068
22. Kalled S. L., Ambrose C., Hsu Y. M., BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders Expert Opinion on Therapeutic Targets 2003 7 1 115 123 (Pubitemid 36204593)
23. Moisini I., Davidson A., BAFF: a local and systemic target in autoimmune diseases Clinical and Experimental Immunology 2009 158 2 155 163